NCT07549139 Overcoming Racial Disparities in Screening Mammography Status NOT_YET_RECRUITING Phase NA
NCT07146646 Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer Status RECRUITING Phase PHASE2
NCT07030400 Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma Status RECRUITING Phase N/A
NCT06650579 REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial Status RECRUITING Phase PHASE3
NCT06483100 Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance Status RECRUITING Phase PHASE2
NCT06463457 Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06396598 Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer Status RECRUITING Phase NA
NCT06138561 Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments Status RECRUITING Phase N/A
NCT06109467 Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer Status RECRUITING Phase PHASE2
NCT06064149 The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study Status RECRUITING Phase NA
NCT05879913 ASCVD Management Using CCTA in Prostate Cancer Patients on ADT Status RECRUITING Phase NA
NCT05799079 Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant Status TERMINATED Phase PHASE2
NCT05292521 Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer Status RECRUITING Phase NA
NCT05274048 Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients Status RECRUITING Phase PHASE1
NCT05089370 Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05037500 Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT05036681 A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma Status TERMINATED Phase PHASE2